Nicolas Daniel Romero Gomez
Universidad de Ciencias Aplicadas y Ambientales
H-index: 46
Latin America-Colombia
Top articles of Nicolas Daniel Romero Gomez
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Treatment with simvastatin and rifaximin restores the plasma metabolomic profile in patients with decompensated cirrhosis | Hepatology communications | Elisa Pose Elsa Solà Juan J Lozano Adrià Juanola Julia Sidorova | 2022/5 |
Herbal and dietary Supplements-Induced liver injury in Latin America: experience from the Latindili network | Clinical Gastroenterology and Hepatology | Fernando Bessone Miren García-Cortés Inmaculada Medina-Caliz Nelia Hernandez Raymundo Parana | 2022/3/1 |
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation | AJ Montano-Loza V Ronca M Ebadi BE Hansen G Hirschfield | 2022 | |
Genetic risk factors in drug‐induced liver injury due to isoniazid‐containing antituberculosis drug regimens | Clinical Pharmacology & Therapeutics | Paola Nicoletti Harshad Devarbhavi Ashish Goel Radha Venkatesan Chundamannil E Eapen | 2021/4 |
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium | Journal of hepatology | Elsa Solà Elisa Pose Daniela Campion Salvatore Piano Olivier Roux | 2021/1/1 |
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry | Journal of hepatology | Camilla Stephens Mercedes Robles-Diaz Inmaculada Medina-Caliz Miren Garcia-Cortes Aida Ortega-Alonso | 2021/7/1 |
Serious liver injury induced by Nimesulide: an international collaborative study | Archives of Toxicology | Fernando Bessone Nelia Hernandez Manuel Mendizabal Ezequiel Ridruejo Gisela Gualano | 2021/4 |
The use of rifaximin in patients with cirrhosis | Paolo Caraceni Victor Vargas Elsa Solà Carlo Alessandria Koos de Wit | 2021/9 | |
Clinical characteristics and outcome of drug‐induced liver injury in the older patients: From the young‐old to the oldest‐old | Clinical Pharmacology & Therapeutics | Rianne A Weersink Ismael Alvarez‐Alvarez Inmaculada Medina‐Cáliz Judith Sanabria‐Cabrera Mercedes Robles‐Díaz | 2021/4 |
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: a longitudinal study of 1893 biopsy‐proven nonalcoholic fatty liver … | Liver International | Javier Ampuero Rocío Aller Rocío Gallego‐Durán Javier Crespo Javier Abad | 2021/9 |
Description of HBV-infected persons presenting late to specialist care in 10 Spanish centres: A retrospective registry review | Journal of Hepatology | Maria Buti Camila Picchio Sabela Lens Manuel Romero Gomez Raul J Andrade | 2020/8/1 |
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial | The Lancet Gastroenterology & Hepatology | Elisa Pose Laura Napoleone Ahmed Amin Daniela Campion César Jimenez | 2020/1/1 |
Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective … | Alimentary pharmacology & therapeutics | Pietro Lampertico Thomas Berg Maria Buti Anita Pathil Joerg Petersen | 2020/8 |
Development and validation of hepamet fibrosis scoring system–a simple, noninvasive test to identify patients with nonalcoholic fatty liver disease with advanced fibrosis | Clinical Gastroenterology and Hepatology | Javier Ampuero Raluca Pais Rocío Aller Rocío Gallego-Durán Javier Crespo | 2020/1/1 |
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH | Journal of Hepatology | Javier Ampuero Rocío Aller Rocío Gallego-Durán Javier Crespo José Luis Calleja | 2020/7/1 |
Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts | José Luis Calleja-Panero Raúl J Andrade Rafael Bañares Javier Crespo Rafael Esteban | 2020 | |
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure | Antiviral Research | Qian Chen Celia Perales María Eugenia Soria Damir García-Cehic Josep Gregori | 2020/2/1 |
Nursing Care of Patients With Cirrhosis: The LiverHope Nursing Project | Hepatology, 2020, vol. 71, num. 3, p. 1106-1116 | Núria Fabrellas i Padrès Marta Carol Ester Palacio Marites Aban Tommaso Lanzillotti | 2020/3/1 |
Erratum to:“Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17–25) | Journal of Hepatology | Javier Ampuero Rocío Aller Rocío Gallego-Durán Javier Crespo José Luis Calleja | 2020/9/1 |
